Cargando…
Erlotinib Achieved Partial Response in a Non-Small Cell Lung Cancer Patient with Gefitinib-Induced Interstitial Lung Disease
Interstitial lung disease (ILD) induced by epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs), such as gefitinib and erlotinib, is a rare but fatal complication of TKI treatment. Transfer to chemotherapy or continuation with TKI of reduced dose are alternative treatment strategi...
Autores principales: | Tian, Qing, Chen, Liang-an |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3220897/ https://www.ncbi.nlm.nih.gov/pubmed/22114570 http://dx.doi.org/10.1159/000332195 |
Ejemplares similares
-
Interstitial Granulomatous Dermatitis: Another Clinical Variant
por: Patsatsi, Aikaterini, et al.
Publicado: (2011) -
Near Total Regression of Diffuse Brain Metastases in Adenocarcinoma of the Lung with an EGFR Exon 19 Mutation: A Case Report and Review of the Literature
por: Tang, Wen-Hao, et al.
Publicado: (2011) -
Rectal Small Cell Carcinoma: A Case Report and Review of the Literature
por: Spiliopoulou, Paulina, et al.
Publicado: (2011) -
Small Bowel Adenocarcinoma Presenting with Refractory Iron Deficiency Anemia – Case Report and Review of Literature
por: Poddar, Nishant, et al.
Publicado: (2011) -
Case Study in Refractory Non-Hodgkin's Lymphoma: Successful Treatment with Plerixafor
por: Azim, Hamdy Abdel, et al.
Publicado: (2011)